See more : Kingswood Holdings Limited (KWG.L) Income Statement Analysis – Financial Results
Complete financial analysis of China Life Insurance Company Limited (LFC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Life Insurance Company Limited, a leading company in the Insurance – Life industry within the Financial Services sector.
- PT Royalindo Investa Wijaya Tbk (INDO.JK) Income Statement Analysis – Financial Results
- Tsim Sha Tsui Properties Limited (0247.HK) Income Statement Analysis – Financial Results
- Sabina Gold & Silver Corp. (SBB.TO) Income Statement Analysis – Financial Results
- DAEWON Chemical Co., Ltd. (024890.KS) Income Statement Analysis – Financial Results
- Ferretti S.p.A. (9638.HK) Income Statement Analysis – Financial Results
China Life Insurance Company Limited (LFC)
About China Life Insurance Company Limited
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/women/pension, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 734.85B | 803.98B | 824.53B | 804.96B | 729.47B | 627.42B | 643.36B | 540.78B | 507.45B | 440.77B | 417.88B | 371.49B | 370.90B | 385.84B | 339.29B | 166.81B | 191.37B | 147.31B | 98.21B | 76.81B | 78.88B | 74.31B | 61.21B |
Cost of Revenue | -94.41B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 829.26B | 803.98B | 824.53B | 804.96B | 729.47B | 627.42B | 643.36B | 540.78B | 507.45B | 440.77B | 417.88B | 371.49B | 370.90B | 385.84B | 339.29B | 166.81B | 191.37B | 147.31B | 98.21B | 76.81B | 78.88B | 74.31B | 61.21B |
Gross Profit Ratio | 112.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 41.08B | 39.87B | 40.81B | 37.69B | 40.28B | 37.49B | 35.95B | 31.85B | 27.46B | 25.43B | 24.81B | 23.28B | 0.00 | 20.29B | 18.72B | 12.11B | 11.80B | 9.34B | 7.24B | 6.59B | 6.86B | 0.00 | 0.00 |
Selling & Marketing | -949.00M | 2.89B | 2.92B | 2.67B | 3.23B | 3.08B | 3.23B | 2.83B | 2.51B | 2.47B | 2.68B | 3.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 40.13B | 39.87B | 40.81B | 37.69B | 40.28B | 37.49B | 35.95B | 31.85B | 27.46B | 25.43B | 24.81B | 23.28B | 21.55B | 20.29B | 18.72B | 12.11B | 11.80B | 9.34B | 7.24B | 6.59B | 6.86B | 0.00 | 5.10B |
Other Expenses | 682.48B | -816.37B | -826.34B | -798.59B | -718.88B | -647.41B | -637.64B | -548.79B | -488.98B | -425.80B | -416.36B | -383.80B | -371.22B | -366.89B | -316.97B | -156.35B | -158.19B | -131.05B | -93.94B | -73.89B | -86.01B | -77.82B | -71.02B |
Operating Expenses | 722.61B | -776.50B | -785.53B | -760.91B | -678.60B | -609.92B | -601.68B | -516.94B | -461.52B | -400.36B | -391.56B | -360.52B | -349.67B | -346.60B | -298.25B | -144.24B | -146.39B | -121.71B | -86.70B | -67.30B | -79.15B | -77.82B | -65.92B |
Cost & Expenses | 722.61B | 779.93B | 774.03B | 750.47B | 669.68B | 613.50B | 601.68B | 516.94B | 461.52B | 400.36B | 388.43B | 360.52B | 350.39B | 344.83B | 297.55B | 144.01B | 145.98B | 121.71B | 86.70B | 67.30B | 79.15B | 1.66B | 7.28B |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.35B | 0.00 | 6.74B | 3.97B | 0.00 | 0.00 |
Interest Expense | 0.00 | 4.86B | 5.60B | 3.75B | 4.26B | 4.12B | 4.60B | 4.77B | 4.32B | 4.73B | 4.03B | 2.58B | 873.00M | 27.26B | 0.00 | 0.00 | 0.00 | 1.00B | 705.00M | 4.32B | 1.00M | 0.00 | 0.00 |
Depreciation & Amortization | 4.76B | 5.29B | 4.88B | 4.75B | 4.38B | 2.45B | 2.18B | 2.04B | 2.04B | 2.12B | 2.03B | 1.95B | 1.91B | 1.80B | 1.56B | 1.35B | 14.53B | 11.17B | 8.71B | 6.92B | 6.31B | 0.00 | 0.00 |
EBITDA | 0.00 | 55.66B | 75.26B | 50.89B | 55.25B | 24.19B | 48.96B | 29.93B | 51.42B | 46.63B | 35.46B | 15.83B | 24.33B | 44.12B | 45.47B | 24.50B | 37.06B | 27.51B | 26.09B | 13.82B | 7.28B | -3.51B | -4.71B |
EBITDA Ratio | 0.00% | 4.08% | 5.37% | 6.11% | 7.57% | 3.21% | 7.46% | 5.59% | 10.21% | 10.65% | 8.44% | 4.11% | 6.24% | 11.05% | 12.72% | 14.40% | 31.31% | 24.96% | 20.59% | 21.32% | 7.68% | -4.72% | -7.69% |
Operating Income | 12.24B | 27.48B | 39.00B | 44.06B | 50.87B | 17.50B | 41.67B | 23.84B | 45.93B | 40.40B | 26.33B | 10.97B | 21.23B | 39.24B | 41.04B | 22.58B | 44.98B | 25.61B | 11.51B | 9.50B | -263.00M | -3.51B | -4.71B |
Operating Income Ratio | 1.67% | 3.42% | 4.73% | 5.47% | 6.97% | 2.79% | 6.48% | 4.41% | 9.05% | 9.17% | 6.30% | 2.95% | 5.72% | 10.17% | 12.10% | 13.53% | 23.51% | 17.38% | 11.72% | 12.37% | -0.33% | -4.72% | -7.69% |
Total Other Income/Expenses | -363.00M | -336.00M | -41.24B | -8.76B | -195.00M | -16.49B | -211.00M | -245.00M | -82.00M | 149.00M | 548.00M | -342.00M | -17.62B | -5.17B | 0.00 | -2.62B | -5.58B | -996.00M | -11.62B | -6.35B | 1.23B | -2.00M | 6.00M |
Income Before Tax | 11.88B | 24.05B | 50.50B | 54.49B | 59.80B | 13.92B | 41.67B | 23.84B | 45.93B | 40.40B | 29.45B | 10.97B | 20.51B | 41.01B | 41.75B | 22.80B | 45.39B | 25.61B | 11.51B | 9.50B | -263.00M | -3.51B | -4.70B |
Income Before Tax Ratio | 1.62% | 2.99% | 6.12% | 6.77% | 8.20% | 2.22% | 6.48% | 4.41% | 9.05% | 9.17% | 7.05% | 2.95% | 5.53% | 10.63% | 12.30% | 13.67% | 23.72% | 17.38% | 11.72% | 12.37% | -0.33% | -4.72% | -7.68% |
Income Tax Expense | -10.76B | -9.47B | -1.92B | 3.10B | 781.00M | 1.99B | 8.92B | 4.26B | 10.74B | 7.89B | 4.44B | -304.00M | 2.02B | 7.20B | 8.71B | 1.39B | 6.33B | 5.55B | 2.15B | 2.28B | 1.18B | 14.00M | 4.00M |
Net Income | 21.11B | 32.08B | 50.77B | 50.26B | 58.29B | 11.40B | 32.25B | 19.13B | 34.70B | 32.21B | 24.77B | 11.06B | 18.33B | 33.63B | 32.88B | 21.28B | 39.06B | 20.05B | 9.37B | 7.17B | -1.43B | -3.52B | -4.71B |
Net Income Ratio | 2.87% | 3.99% | 6.16% | 6.24% | 7.99% | 1.82% | 5.01% | 3.54% | 6.84% | 7.31% | 5.93% | 2.98% | 4.94% | 8.72% | 9.69% | 12.76% | 20.41% | 13.61% | 9.54% | 9.34% | -1.81% | -4.74% | -7.70% |
EPS | 0.75 | 1.14 | 1.80 | 1.78 | 2.05 | 0.40 | 1.13 | 0.66 | 1.22 | 1.14 | 0.88 | 0.39 | 0.65 | 1.19 | 1.16 | 0.68 | 1.38 | 0.75 | 0.35 | 0.10 | -0.07 | -0.18 | -0.09 |
EPS Diluted | 0.75 | 1.14 | 1.80 | 1.78 | 2.05 | 0.40 | 1.13 | 0.66 | 1.22 | 1.14 | 0.88 | 0.39 | 0.65 | 1.19 | 1.16 | 0.68 | 1.38 | 0.75 | 0.35 | 0.10 | -0.07 | -0.18 | -0.09 |
Weighted Avg Shares Out | 28.15B | 28.27B | 28.27B | 28.27B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 26.61B | 26.58B | 70.82B | 20.48B | 19.58B | 52.29B |
Weighted Avg Shares Out (Dil) | 28.27B | 28.27B | 28.27B | 28.27B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 28.26B | 26.61B | 26.58B | 70.82B | 20.48B | 19.58B | 52.29B |
China Life Insurance: Embarking On A Revitalization Strategy
Edited Transcript of 601628.SS earnings conference call or presentation 23-Apr-20 11:45am GMT
Futures Rebound From Earlier Losses As Corona Optimism Returns
Asian Stocks Rallyon Back of Rising Oil Prices
TalkMarkets Topics – Major Stock Exchanges Of The World
12 of the Best Emerging Markets Stocks to Buy
Stock Analysts' Updated EPS Estimates for February, 3rd (AAPL, ALV, AMRN, BNFT, CCEP, DGEAF, ENGI, FHB, FTV, IAC)
Source: https://incomestatements.info
Category: Stock Reports